Kenneth Allen Myszkowski, Chief Financial Officer at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 37,884 shares at $40.56 ($1.5M) on 2019-11-01, disclosed to the SEC on 2019-11-01.
Open-market sale of $1.5M ARWR by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.56 | 21,264 | $862K | 55.7% |
| 2 | $41.21 | 16,620 | $685K | 44.3% |
| Total | $40.85 avg | 37,884 | $1.5M | 100% |
| Filing → |
| ARWR | SELL | 2024-01-08 | $885K | — | Filing → |
| ARWR | SELL | 2023-06-29 | $543K | — | Filing → |
| ARWR | SELL | 2022-12-30 | $1.2M | — | Filing → |